August 2, 2017
MDH Commissioner Statement on Medical Cannabis Manufacturers’ Re-Registration
Minnesota Commissioner of Health Dr. Ed Ehlinger issued the following statement today regarding his decision to move forward with re-registering LeafLine Labs and Minnesota Medical Solutions (MinnMed) as the manufacturers responsible for growing, processing and distributing medications for the state’s medical cannabis program.
The top priority of our Office of Medical Cannabis is to make a positive difference for the seriously ill patients who participate in the program. Prior to making this decision, I consulted with the staff of the Office of Medical Cannabis and reviewed information provided by experts within the Minnesota Department of Health as well as several other state agencies, including Agriculture, Commerce and Employment and Economic Development. Based on this information and on the department’s assessment of the manufacturers’ ability to meet the needs of patients, I chose to move forward with renewing and updating the registration of the two manufacturers.
We are proud that Minnesota’s medical cannabis program has become a model for other states, but there have been challenges along the way as well. We’ve learned a great deal about how to work with manufacturers and other participants to maximize patient safety and well-being. We will draw on those experiences and on the new, stricter regulatory authorities provided by the 2017 Minnesota Legislature in the new registration agreements with the manufacturers. These updates will mean a stronger program that works even better for patients.
Minnesota’s 2014 law creating the state’s medical cannabis program assigned to the Minnesota Commissioner of Health the task of registering two companies to serve as cannabis manufacturers. This registration is to be reassessed every two years based on available information and performance.
More information about the state’s medical cannabis program is available on the MDH website at Medical Cannabis.